In dit artikel wordt nader ingegaan op de huidige mogelijkheden om op grond van het Nederlands recht palliatief verlof en rouwverlof op te nemen.
The judgment in the Centre hospitalier universitaire de Besançon v Thomas Dutrueux, Caisse primaire d'assurance maladie du Jura case that I wrote about earlier has been handed down by the EU Court on 21 December and as expected, the EU Court followed its Advocate General.
Now here is an important case for the medical devices industry. Although product liability litigation has not (yet) evolved into the type of bet the company litigation it can be in the United States and cases about interpretation of the Product Liability Directive have been few, they do shape the scope of no fault liability in the EU of manufacturers of medical devices for their products.
Recently, CBD food products were qualified as Novel Foods requiring a market authorization. The lively trade in these products ...
As of March 2019, Amsterdam will be the proud home of the European Medicines Agency (EMA). It's been confirmed that the EMA will relocate its headquarters from London to Amsterdam due to Brexit.
Probiotics are known as "beneficial bacteria" that can be found in, amongst others, dairy products and food supplements.
Last week, the creation of the new Advisory Group on the Status of Borderline Products was published in the Dutch Government Gazette.
IPPZ is a company that develops software for health care professionals.
The DHA announced that it will stop providing data from the DIS to third parties while the investigation is ongoing.
AKD advocaten & notarissen
The Netherlands still has relatively little experience with hospitals that are entirely in the hands of an investor.
De Brauw Blackstone Westbroek N.V.
The health care sector is likely to stay on the ACM's radar.
The Court of Appeals of The Hague has recently ruled that healthcare insurance companies, by inviting parties to bid in a tender to become the preferred supplier of a medicinal product which is still under patent protection, do not infringe the originator's patent and do not commit an "unlawful act".
Kennedy van der Laan
The intention of the bill is to make it possible for providers of medical specialist care to distribute profits, under circumstances.
On 10 May, Edith Schippers, the Health Secretary in the Dutch Rutte I Government, which tendered its resignation at the beginning of the month, submitted a Draft Act on Continuity, Mergers and Divestments in the Healthcare Sector to the Dutch Lower House.
De Brauw Blackstone Westbroek N.V.
The healthcare sector is one of the NMa's focus industries, which means it is subject to closer investigation.
Although no significant things happened in business compliance developments on a EU level for some time since Eucomed asked itself about guidance for sponsorship of conferences, things are very much in flux in the Netherlands.
I have been running around a lot lately doing presentations on conferences about medical devices and software, so I though it would be useful to give you a round-up on that subject.
Right after the event I wrote about in my previous post I visited the Eucomed MedTech conference in Brussels on 12-14 October 2011.
On 23 September 2011 the draft of the e-labelling regulation that I wrote about earlier was discussed in the comitiology committee for the Medical Devices Directive.
Today I attended the COCIR workshop Regulating Medical Software in Brussels, a very interesting event that brought a lot of new information to my attention and I had the opportunity to speak to many people close to developments in EU legislation, EU guidance and standards.